Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Invent Farma Holding Spain S.L.

Created in August 2016, following the acquisition by funds advised by Apax Partners, the Group Invent Farma / neuraxpharm is a leader in generic pharmaceutical products for the treatment of disorders of the central nervous system (CNS). The Group is the combination of the Barcelona-based Invent Farma with Düsseldorf-based neuraxpharm. Invent Farma has 50 years’ experience in the development, manufacturing and marketing of pharmaceutical products, while neuraxpharm is a leading CNS brand that has earned the trust of specialist doctors, pharmacists and patients in over three decades. The Group markets, through Qualigen and neuraxpharm, generics drugs from a combined portfolio of predominantly differentiated products mainly in the CNS field. In addition, the Group owns and operates two manufacturing plants in Spain: one of the plants to produce hard-to-make active pharmaceutical ingredients (APIs) with a unique expertise in the respiratory area (Inke), and the other one to produce finished dosage forms (FDFs) across multiple therapeutic areas (Lesvi). *

 

Period Start 2016-08-01 existent
  Group NuPharm (Group)
Products Industry CNS drug (neurological drug)
  Industry 2 DRUGS, GENERICS
Person Person Walz, Stephan (Invent Pharma / Neuraxpharm 201706 CEO)
     
Region Region Barcelona
  Country Spain (España)
  Street 69 Avda. Barcelona
  City 08970 Sant Joan Despi (Barcelona)
  Tel +34-93-475-9600
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf.
     
   
Record changed: 2023-07-10

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for NuPharm (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top